Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Trump’s Department of War bets $47M on Flagship biotechs to develop countermeasures

Trump’s Department of War bets $47M on Flagship biotechs to develop countermeasures

September 23, 2026Posted inBiotechnology

The Department of War has awarded Flagship Pioneering $47 million to develop medical countermeasure technologies against emerging threats.

Post navigation

Previous Post
Enveda reaps $311M series E to feed ambition to become a ‘household name’
Next Post
New Immune Checkpoint Discovery Explains Why Gastric Cancers Ignore PD-1 Drugs new-immune-checkpoint-discovery-explains-why-gastric-cancers-ignore-pd-1-drugs

Recent Posts

  • Hidden Mosquito Diversity Surfaces in Mexico’s Celestún Mangrove Reserve
  • RNA Tagging Machine Behind Endometriosis Blood Vessel Growth Revealed
  • School Program Boosts Sun-Safety Habits in High-Altitude Andean Teens
  • Holography Breakthrough Turns Crosstalk Into Signal for Truly Continuous 3D Displays
  • Microscopic robots now sense heat and pump fluid to reshape their surroundings

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top